Patent · US Active

Azaindole rock inhibitors

US12240848B2 · kind B2 · utility

1Cited by
2References
13Claims
0Family size

Assignee

Inventor

Key dates

Filing dateMar 19, 2024
Grant dateMar 4, 2025
Priority date
Expiry dateMar 19, 2044

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K47/38
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention provides rho-associated protein kinase (ROCK) inhibiting compounds for therapeutic applications as described further herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.